Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HSTM
HSTM logo

HSTM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy HealthStream Inc (HSTM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
25.640
1 Day change
-1.38%
52 Week Range
29.620
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

HealthStream Inc (HSTM) does not present a strong buy opportunity for a beginner investor with a long-term focus and $50,000-$100,000 available. The stock lacks clear positive catalysts, has neutral technical indicators, and insider selling activity suggests caution. Additionally, there are no strong proprietary trading signals or recent financial performance data to support a buy decision.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 48.495, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot level of 25.828, with support at 25.095 and resistance at 26.562. Overall, the technical indicators are mixed and do not provide a strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data shows heightened investor interest with 2,172 contracts traded, particularly in the $30 strike call option (2,146 contracts), reflecting optimistic sentiment. However, the low put-call ratios and limited volume suggest speculative activity rather than strong conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • The $30 strike call option activity indicates some market optimism for price increases.

Neutral/Negative Catalysts

  • Insider selling has increased by 146.37% over the last month, and hedge funds are neutral. Analysts have raised the price target to $24 (below the current price), citing consistent revenue growth headwinds. Technical indicators show bearish momentum, and there is no recent congress trading data or strong financial performance to support a buy decision.

Financial Performance

No financial performance data is available for analysis due to an error in the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Canaccord raised the price target to $24 from $21 but maintained a Hold rating, citing consistent revenue growth challenges due to churn in legacy products.

Wall Street analysts forecast HSTM stock price to fall
4 Analyst Rating
Wall Street analysts forecast HSTM stock price to fall
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 26.000
sliders
Low
25
Averages
25
High
25
Current: 26.000
sliders
Low
25
Averages
25
High
25
Canaccord
Hold
maintain
$21 -> $24
AI Analysis
2026-05-06
Reason
Canaccord
Price Target
$21 -> $24
AI Analysis
2026-05-06
maintain
Hold
Reason
Canaccord raised the firm's price target on HealthStream to $24 from $21 and keeps a Hold rating on the shares. The firm updated its model following Q1 results and where the overhang of churn in legacy Credentialing and Scheduling products has been a consistent headwind to revenue growth for several quarters.
Canaccord
Hold
downgrade
$25 -> $21
2026-02-25
Reason
Canaccord
Price Target
$25 -> $21
2026-02-25
downgrade
Hold
Reason
Canaccord lowered the firm's price target on HealthStream to $21 from $25 and keeps a Hold rating on the shares. The firm said HealthStream's 4Q'25 results were respectable amid rising concerns of AI disintermediation of SaaS names. Management addressed the AI concerns on the conference call, making a compelling case how HealthStream is more favorably positioned than other software names in the broader landscape.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HSTM
Unlock Now

People Also Watch